Profile for Peter Wilker
Contact me
Peter Wilker
Pronouns: He/Him/His
Associate Professor
Microbiology
University of Wisconsin-La Crosse
Peter Wilker Pronouns: He/Him/His
Associate Professor
Microbiology
Specialty area(s)
Immunology, influenza viruses
Education
B.A. Biology - Saint Olaf College
M.P.H. Epidemiology - University of Minnesota
Ph.D. Immunology - Washington University in Saint Louis
Career
Teaching history
Global Impact of Infectious Disease, MIC 130
Fundamentals of Microbiology Laboratory, MIC 230
Immunology, MIC 310
Immunology Laboratory, MIC 410
Advanced Immunology, MIC 755
Epidemiology of Infectious Diseases, MIC 753
Introductory Virology, MIC 420
Research and publishing
Liu J, Ren Z, Wang H, Zhao Y, Wilker PR, Yu Z, Sun W, Wang T, Feng N, Li Y, Wang H. Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses. International immunopharmacology. 2018 Oct 1;63:119-28.
Zhang K, wei Xu W, Zhang Z, Li J, Sun L, Sun W, Jiao P, Sang X, Ren Z, Yu Z, Li Y. The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection. Oncotarget. 2017 Mar 23;8(18):30422.
Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M. Selection of antigenically advanced variants of seasonal influenza viruses. Nature microbiology. 2016 May 23;1(6):1-0.
Feng, Na, Yicong Yu, Tiecheng Wang, Peter Wilker, Jianzhong Wang, Yuanguo Li, Zhe Sun, Yuwei Gao, and Xianzhu Xia. "Fatal canine distemper virus infection of giant pandas in China." Scientific reports 6, no. 1 (2016): 27518.
Zhijun Yu, Kaihui Cheng, Weiyang Sun, Xinghai Zhang, Yuanguo Li, Tiecheng Wang, Hualei Wang, Qianyi Zhang, Yue Xin, Xue Li, Kun Zhang, Jing Huang, Songtao Yang, Chuan Qin, Peter R. Wilker, Donghui Yue, Hualan Chen, Yuwei Gao, Xianzhu Xia.A PB1 T296R substitution enhances polymerase activity and confer a virulent phenotype to a 2009 pandemic H1N1 influenza virus in mice. Virology. 2015 Dec 1;486:180-6.
Wilker PR, Dinis JM, Starrett G, Imai M, Hatta M, Nelson CW, et al. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses. Nat Commun 2013, 4: 2636.
Das SC, Hatta M, Wilker PR, Myc A, Hamouda T, Neumann G, et al. Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. Vaccine 2012, 30(48):6871-6877.
Smith KE, Wilker PR, Reiter PL, Hedican EB, Bender JB, Hedberg CW. Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota. Pediatr Infect Dis J 2012, 31(1): 37-41.
Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A 2011, 108(29): 12018-12023.
Kohyama M, Ise W, Edelson BT, Wilker PR, Hildner K, Mejia C, et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 2009, 457(7227): 318-321.
Wilker PR, Kohyama M, Sandau MM, Albring JC, Nakagawa O, Schwarz JJ, et al. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat Immunol 2008, 9(6): 603-612.
Wilker PR, Sedy JR, Grigura V, Murphy TL, Murphy KM. Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family. Int Immunol 2007, 19(6): 763-773.
Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies. Blood 2006, 108(3): 922-927.
Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002, 100(6): 2071-2076.
Cunha PD, Lord RS, Johnson ST, Wilker PR, Aster RH, Bougie DW. Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug. Transfusion 2000, 40(6): 663-668.